表紙
市場調查報告書

全球動物用醫藥品CRO(臨床研究委外機構)市場:服務類型,用途,各終端用戶 - 機會分析與產業預測(2019年∼2026年)

Veterinary CRO Market by Service Type, Application, End User : Global Opportunity Analysis and Industry Forecast, 2019 - 2026

出版商 Allied Market Research 商品編碼 923931
出版日期 內容資訊 英文 181 Pages
商品交期: 2-3個工作天內
價格
全球動物用醫藥品CRO(臨床研究委外機構)市場:服務類型,用途,各終端用戶 - 機會分析與產業預測(2019年∼2026年) Veterinary CRO Market by Service Type, Application, End User : Global Opportunity Analysis and Industry Forecast, 2019 - 2026
出版日期: 2019年12月09日內容資訊: 英文 181 Pages
簡介

全球動物用醫藥品CRO(臨床研究委外機構)市場在2018年估算為4億8,550萬美元的規模。該市場在2019年∼2026年間,預測將以7.9%的年複合成長率增長,2026年達到8億9,470萬美元的規模。擁有伴侶動物的增加和動物保健方面的支出增加。伴侶動物中各種疾病的患病率上升也是市場增長的主要因素。儘管缺乏獸藥CRO的標準化可能會阻礙市場的增長,但預計全球對動物醫療相關意識將在預測期內提供豐厚的市場機會。

本報告提供全球動物用醫藥品CRO市場的相關調查,提供市場機會和影響,成長及阻礙因素,各服務類型·動物類型·適應症·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 報告的說明
  • 利害關係者的主要優點
  • 主要市場區隔
    • 被本報告刊載的主要企業的清單
  • 調查方法
    • 二次調查
    • 一次調查
    • 分析師的工具和模式

第2章 摘要整理

  • 主要調查結果
    • 主要的影響要素
    • 主要的投資品牌
  • Cxo的見解

第3章 市場概要

  • 市場定義和範圍
  • 波特的五力分析
  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 影響分析

第4章 市場分析:各服務形式

  • 概要
    • 市場規模與預測
  • 臨床試驗
  • 毒理學
  • 市場核准·規定支援
  • 其他

第5章 市場分析:各動物類型

  • 概要
    • 市場規模與預測
  • 其他

第6章 市場分析:各適應症

  • 概要
    • 市場規模與預測
  • 腫瘤學
  • 感染疾病
  • 神經學
  • 其他

第7章 市場分析:各地區

  • 概要
    • 市場規模與預測
  • 北美
  • 歐洲
  • 亞太地區
  • 南美·中東·非洲

第8章 競爭情形

  • 簡介
    • 市場參與企業的地位(2018年)
  • 成功策略主要的開發
  • 競爭儀表板
  • 競爭熱圖

第9章 企業簡介

  • Charles River Laboratories, Inc.
  • Clinvet
  • Klifovet Ag
  • Lohlein & Wolf Vet Research
  • Oncovet Clinical Research
  • Ondax Scientific
  • Triveritas
  • Veterinary Research Management (Vrm) Ltd
  • Vetpharm, Inc.
  • Vetspin Srl
目錄
Product Code: LI_196265

The global veterinary CRO market was valued at $485.5 million in 2018, and is expected to reach $894.7 million by 2026, registering a CAGR of 7.9% from 2019 to 2026.

Contract research organizations (CROs) are companies that aid in conducting research for a sponsor company. Moreover, veterinary CROs are companies, which are specialized in in-vivo studies that involve companion animals. Sponsor companies seek provision from veterinary CROs to support research and development programs for biopharmaceutical industries. Furthermore, different types of services are provided by veterinary CROs such as clinical trials, toxicology, and market authorization & regulatory support. These services are utilized by veterinary medicine manufacturers to test the safety and efficacy of veterinary drugs, which are used in different indications such as oncology, neurology, and infectious diseases.

The factors that boost the growth of the veterinary CRO market include surge in ownership of companion animals and rise in animal health expenditure. Furthermore, other factors such as increase in prevalence of various diseases among companion animal acts as a major factor that contributes toward the growth of the market. However, lack of standardization in veterinary CROs is a factor that restrains the growth of the market. Conversely, surge in awareness related to animal healthcare across the globe is expected to provide lucrative opportunities in the market during the forecast period.

The veterinary CRO market is segmented into service type, animal type, indication, and region. On the basis of service type, the market is divided into clinical trials, toxicology, market authorization & regulatory support, and others. By animal type, the market is classified into dogs, cats, and others. Depending on indication, it is categorized into oncology, infectious disease, neurology, and others. Region wise, it is analyzed across North America (U.S, Canada, and Mexico) and Europe (Germany, France, Italy, Spain, UK and rest of Europe), Asia-Pacific (Japan, China, Australia, rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa and rest of LAMEA).

XXXXXKEY BENEFITS FOR STAKEHOLDERSYYYYY

This report entails a detailed quantitative analysis along with the current global veterinary CRO market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.

The market size and estimations are based on a comprehensive analysis of key developments in the industry.

A qualitative analysis based on innovative service types facilitates strategic business planning.

The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments

By Service Type

Clinical Trials

Toxicology

Market Authorization & Regulatory Support

Others

By Animal Type

Dogs

Cats

Others

By Indication

Oncology

Infectious Disease

Neurology

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Rest of Europe

Asia-Pacific

Japan

China

Australia

Rest of Asia-Pacific

LAMEA

Brazil

Saudi Arabia

South Africa

Rest Of LAMEA

List of key players profiled in the report:

  • Charles River Laboratories, Inc.
  • Clinvet
  • KLIFOVET AG
  • Lohlein & Wolf Vet Research
  • Oncovet Clinical Research
  • ONDAX Scientific
  • Triveritas
  • Veterinary Research Management (VRM) Ltd
  • VetPharm, Inc.
  • VETSPIN SRL
  • LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
  • AlcheraBio
  • Likarda

Table of Contents

Chapter 1: Introduction

  • 1.1. Report Description
  • 1.2. Key Benefits For Stakeholders
  • 1.3. Key Market Segments
    • 1.3.1. List of Key Players Profiled In The Report
  • 1.4. Research Methodology
    • 1.4.1. Secondary Research
    • 1.4.2. Primary Research
    • 1.4.3. Analyst Tools And Models

Chapter 2: Executive Summary

  • 2.1. Key Findings of The Study
    • 2.1.1. Top Impacting Factors
    • 2.1.2. Top Investment Pockets
  • 2.2. Cxo Perspective

Chapter 3: Market Overview

  • 3.1. Market Definition And Scope
  • 3.2. Porter'S Five Forces Analysis
    • 3.2.1. Bargaining Power of Buyers
    • 3.2.2. Bargaining Power of Suppliers
    • 3.2.3. Thereat of New Entrants
    • 3.2.4. Threat of Substitutes
    • 3.2.5. Intensity of Competitive Rivalry
  • 3.3. Market Dynamics
    • 3.3.1. Drivers
      • 3.3.1.1. Surge In Ownership of Companion Animals
      • 3.3.1.2. Rise In Animal Health Expenditure
      • 3.3.1.3. Increase In Prevalence of Various Diseases Among Companion Animals
    • 3.3.2. Restraint
      • 3.3.2.1. Lack of Standardization In Veterinary Cros
    • 3.3.3. Opportunity
      • 3.3.3.1. Surge In Awareness Related To Animal Healthcare
    • 3.3.4. Impact Analysis

Chapter 4: Veterinary Cro Market, By Service Type

  • 4.1. Overview
    • 4.1.1. Market Size And Forecast
  • 4.2. Clinical Trials
    • 4.2.1. Key Market Trends And Growth Opportunities
    • 4.2.2. Market Size And Forecast, By Region
    • 4.2.3. Market Analysis By Country
  • 4.3. Toxicology
    • 4.3.1. Key Market Trends And Growth Opportunities
    • 4.3.2. Market Size And Forecast, By Region
    • 4.3.3. Market Analysis By Country
  • 4.4. Market Authorization And Regulatory Support
    • 4.4.1. Key Market Trends And Growth Opportunities
    • 4.4.2. Market Size And Forecast, By Region
    • 4.4.3. Market Analysis By Country
  • 4.5. Others
    • 4.5.1. Key Market Trends And Growth Opportunities
    • 4.5.2. Market Size And Forecast, By Region
    • 4.5.3. Market Analysis By Country

Chapter 5: Veterinary Cro Market, By Animal Type

  • 5.1. Overview
    • 5.1.1. Market Size And Forecast
  • 5.2. Dogs
    • 5.2.1. Market Size And Forecast, By Region
    • 5.2.2. Market Analysis By Country
  • 5.3. Cats
    • 5.3.1. Market Size And Forecast, By Region
    • 5.3.2. Market Analysis By Country
  • 5.4. Others
    • 5.4.1. Market Size And Forecast, By Region
    • 5.4.2. Market Analysis By Country

Chapter 6: Veterinary Cro Market, By Indication

  • 6.1. Overview
    • 6.1.1. Market Size And Forecast
  • 6.2. Oncology
    • 6.2.1. Market Size And Forecast, By Region
    • 6.2.2. Market Analysis By Country
  • 6.3. Infectious Disease
    • 6.3.1. Market Size And Forecast, By Region
    • 6.3.2. Market Analysis By Country
  • 6.4. Neurology
    • 6.4.1. Market Size And Forecast, By Region
    • 6.4.2. Market Analysis By Country
  • 6.5. Others
    • 6.5.1. Market Size And Forecast, By Region
    • 6.5.2. Market Analysis By Country

Chapter 7: Veterinary Cro Market, By Region

  • 7.1. Overview
    • 7.1.1. Market Size And Forecast
  • 7.2. North America
    • 7.2.1. Key Market Trends And Opportunities
    • 7.2.2. Market Analysis By Country
      • 7.2.2.1. U.S.
      • 7.2.2.1.1. U.S. Market Size And Forecast, By Service Type
      • 7.2.2.1.2. U.S. Market Size And Forecast, By Animal Type
      • 7.2.2.1.3. U.S. Market Size And Forecast, By Indication
      • 7.2.2.2. Canada
      • 7.2.2.2.1. Canada Market Size And Forecast, By Service Type
      • 7.2.2.2.2. Canada Market Size And Forecast, By Animal Type
      • 7.2.2.2.3. Canada Market Size And Forecast, By Indication
      • 7.2.2.3. Mexico
      • 7.2.2.3.1. Mexico Market Size And Forecast, By Service Type
      • 7.2.2.3.2. Mexico Market Size And Forecast, By Animal Type
      • 7.2.2.3.3. Mexico Market Size And Forecast, By Indication
    • 7.2.3. North America Market Size And Forecast, By Service Type
    • 7.2.4. North America Market Size And Forecast, By Animal Type
    • 7.2.5. North America Market Size And Forecast, By Indication
  • 7.3. Europe
    • 7.3.1. Key Market Trends And Opportunities
    • 7.3.2. Market Analysis By Country
      • 7.3.2.1. Germany
      • 7.3.2.1.1. Germany Market Size And Forecast, By Service Type
      • 7.3.2.1.2. Germany Market Size And Forecast, By Animal Type
      • 7.3.2.1.3. Germany Market Size And Forecast, By Indication
      • 7.3.2.2. France
      • 7.3.2.2.1. France Market Size And Forecast, By Service Type
      • 7.3.2.2.2. France Market Size And Forecast, By Animal Type
      • 7.3.2.2.3. France Market Size And Forecast, By Indication
      • 7.3.2.3. Uk
      • 7.3.2.3.1. Uk Market Size And Forecast, By Service Type
      • 7.3.2.3.2. Uk Market Size And Forecast, By Animal Type
      • 7.3.2.3.3. Uk Market Size And Forecast, By Indication
      • 7.3.2.4. Italy
      • 7.3.2.4.1. Italy Market Size And Forecast, By Service Type
      • 7.3.2.4.2. Italy Market Size And Forecast, By Animal Type
      • 7.3.2.4.3. Italy Market Size And Forecast, By Indication
      • 7.3.2.5. Spain
      • 7.3.2.5.1. Spain Market Size And Forecast, By Service Type
      • 7.3.2.5.2. Spain Market Size And Forecast, By Animal Type
      • 7.3.2.5.3. Spain Market Size And Forecast, By Indication
      • 7.3.2.6. Rest of Europe
      • 7.3.2.6.1. Rest of Europe Market Size And Forecast, By Service Type
      • 7.3.2.6.2. Rest of Europe Market Size And Forecast, By Animal Type
      • 7.3.2.6.3. Rest of Europe Market Size And Forecast, By Indication
    • 7.3.3. Europe Market Size And Forecast, By Service Type
    • 7.3.4. Europe Market Size And Forecast, By Animal Type
    • 7.3.5. Europe Market Size And Forecast, By Indication
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends And Opportunities
    • 7.4.2. Market Analysis By Country
      • 7.4.2.1. Japan
      • 7.4.2.1.1. Japan Market Size And Forecast, By Service Type
      • 7.4.2.1.2. Japan Market Size And Forecast, By Animal Type
      • 7.4.2.1.3. Japan Market Size And Forecast, By Indication
      • 7.4.2.2. China
      • 7.4.2.2.1. China Market Size And Forecast, By Service Type
      • 7.4.2.2.2. China Market Size And Forecast, By Animal Type
      • 7.4.2.2.3. China Market Size And Forecast, By Indication
      • 7.4.2.3. Australia
      • 7.4.2.3.1. Australia Market Size And Forecast, By Service Type
      • 7.4.2.3.2. Australia Market Size And Forecast, By Animal Type
      • 7.4.2.3.3. Australia Market Size And Forecast, By Indication
      • 7.4.2.4. Rest of Asia-Pacific
      • 7.4.2.4.1. Rest of Asia-Pacific Market Size And Forecast, By Service Type
      • 7.4.2.4.2. Rest of Asia-Pacific Market Size And Forecast, By Animal Type
      • 7.4.2.4.3. Rest of Asia-Pacific Market Size And Forecast, By Indication
    • 7.4.3. Asia-Pacific Market Size And Forecast, By Service Type
    • 7.4.4. Asia-Pacific Market Size And Forecast, By Animal Type
    • 7.4.5. Asia-Pacific Market Size And Forecast, By Indication
  • 7.5. Lamea
    • 7.5.1. Key Market Trends And Opportunities
    • 7.5.2. Market Analysis By Country
      • 7.5.2.1. Brazil
      • 7.5.2.1.1. Brazil Market Size And Forecast, By Service Type
      • 7.5.2.1.2. Brazil Market Size And Forecast, By Animal Type
      • 7.5.2.1.3. Brazil Market Size And Forecast, By Indication
      • 7.5.2.2. South Africa
      • 7.5.2.2.1. South Africa Market Size And Forecast, By Service Type
      • 7.5.2.2.2. South Africa Market Size And Forecast, By Animal Type
      • 7.5.2.2.3. South Africa Market Size And Forecast, By Indication
      • 7.5.2.3. Saudi Arabia
      • 7.5.2.3.1. Saudi Arabia Market Size And Forecast, By Service Type
      • 7.5.2.3.2. Saudi Arabia Market Size And Forecast, By Animal Type
      • 7.5.2.3.3. Saudi Arabia Market Size And Forecast, By Indication
      • 7.5.2.4. Rest of Lamea
      • 7.5.2.4.1. Rest of Lamea Market Size And Forecast, By Service Type
      • 7.5.2.4.2. Rest of Lamea Market Size And Forecast, By Animal Type
      • 7.5.2.4.3. Rest of Lamea Market Size And Forecast, By Indication
    • 7.5.3. Lamea Market Size And Forecast, By Service Type
    • 7.5.4. Lamea Market Size And Forecast, By Animal Type
    • 7.5.5. Lamea Market Size And Forecast, By Indication

Chapter 8: Competitive Landscape

  • 8.1. Introduction
    • 8.1.1. Market Player Positioning, 2018
  • 8.2. Top Winning Strategies And Key Developments
  • 8.3. Competitive Dashboard
  • 8.4. Competitive Heatmap

Chapter 9: Company Profiles

  • 9.1. Charles River Laboratories, Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Operating Business Segments
    • 9.1.4. Product Portfolio
    • 9.1.5. Business Performance
    • 9.1.6. Key Strategic Moves And Developments
  • 9.2. Clinvet
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Operating Business Segments
    • 9.2.4. Product Portfolio
    • 9.2.5. Key Strategic Moves And Developments
  • 9.3. Klifovet Ag
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Operating Business Segments
    • 9.3.4. Product Portfolio
  • 9.4. Lohlein & Wolf Vet Research
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Operating Business Segments
    • 9.4.4. Product Portfolio
    • 9.4.5. Key Strategic Moves And Developments
  • 9.5. Oncovet Clinical Research
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Operating Business Segments
    • 9.5.4. Product Portfolio
  • 9.6. Ondax Scientific
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Operating Business Segments
    • 9.6.4. Product Portfolio
    • 9.6.5. Key Strategic Moves And Developments
  • 9.7. Triveritas
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Operating Business Segments
    • 9.7.4. Product Portfolio
  • 9.8. Veterinary Research Management (Vrm) Ltd
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Operating Business Segments
    • 9.8.4. Product Portfolio
  • 9.9. Vetpharm, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Operating Business Segments
    • 9.9.4. Product Portfolio
  • 9.10. Vetspin Srl
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Operating Business Segments
    • 9.10.4. Product Portfolio